The U.S. Food and Drug Administration has approved Saxenda as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity….
Read More »The Importance of Having Standards So Diabetes Devices Can Communicate
Interoperability protocols unveiled for diabetes technologies… The communication protocols define how diabetes devices such as insulin pumps, blood glucose meters, and continuous glucose monitors talk with each other and with other devices such as smart phones and computers. They were developed jointly by JDRF and the Center for Global eHealth …
Read More »Xultophy
The first insulin/incretin mimetic combination launched overseas, Xultophy is a prefilled pen containing a fixed-ratio combination of insulin degludec and liraglutide, licensed in Europe for the treatment of type 2 diabetes in combination with oral hypoglycemics. Xultophy is the first product to combine a basal insulin and an incretin mimetic …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 11
In this week’s Homerun Slides, we cover the importance of the Incretin Effect with an examination of the mechanisms of action of GLP-1 agonist and DPP-4 inhibitor drugs including the cardioprotective aspects of these medications…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 11 …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #23: Skin and Connective Disorders in Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetes affects the cellular biochemistry of skin and connective tissues, in particular collagen synthesis and structure, as well as cutaneous microvascular blood flow. Several non-infective skin conditions are associated with type 1 and/ or type 2 diabetes (Box 24.1). Diabetic dermopathy (‘shin …
Read More »Adverse Outcomes Up with High A1c in Late Pregnancy for Type 1 Women
An HbA1c of 6.5-6.9% at 26 weeks’ gestation correlated with significantly elevated risk of preterm delivery, preeclampsia, need for neonatal glucose infusion, and a composite adverse outcome… Michael J.A. Maresh, M.D., from St. Mary’s Hospital in Manchester, U.K., and colleagues conducted a prospective assessment involving 725 women with type 1 …
Read More »Misconceptions about the Chemistry of Weight Loss
When people lose weight, where does it actually go? Two Australian researchers found that most people don’t know….
Read More »Statin Therapy Does Not Reduce Risk of Fracture
In an analysis of data from the JUPITER trial, higher baseline hs-CRP level was also not associated with an increased risk of incident fracture…
Read More »Simple Breath Test May Aid Early Diagnosis in Children
Increased breath acetone was linked to increases in beta hydroxybutyrate (a ketone) levels in the blood… Researchers may have identified a chemical marker for type 1 diabetes in the breath of children. Around 1 in 4 children with type 1 diabetes are unaware they have a condition until they develop …
Read More »Are There Good and Bad Carbs for Patients with Diabetes?
New research suggests that for non-diabetic people who follow a healthful diet, the glycemic index may not be very important…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.